Tickers

1. Composite Trajectory Verdict

Given TSLA's capital-intensive manufacturing model and strategic pivot toward AI/robotics, the income statement and cash flow statement carry the most weight: the former reveals a sharp profitability downtrend while the latter shows strengthening free cash flow generation, and the balance sheet (only two annual periods presented) supports liquidity but lacks sufficient history for a trend call.

Composite Trajectory: Mixed

Annual GAAP profitability has deteriorated markedly over the three years presented: net income attributable to common stockholders fell from $14.997B (2023) to $7.091B (2024) to $3.794B (2025), and operating margin compressed from 9.2% to 7.2% to 4.6% (10-K 2025, Consolidated Statements of Operations). Conversely, annual free cash flow (operating cash flow minus capital expenditures) improved from $4.36B (2023) to $3.58B (2024) to $6.22B (2025), with cash and short-term investments rising to $44.06B (10-K 2025, Consolidated Statements of Cash Flows; Consolidated Balance Sheets). The quarterly comparison (Q2 2026 vs Q2 2025) shows revenue growth of 26% but a slight decline in net income attributable to common stockholders ($1.11B vs $1.17B) and a drop in six-month free cash flow to $358M from $809M (10-Q 2026-06-30, MD&A Overview; Consolidated Statements of Cash Flows). These opposing directions — earnings deterioration vs. cash flow improvement — drive the Mixed assessment.

2. Red Flags

• Net income collapse: Net income attributable to common stockholders dropped 75% over two years, from $14.997B (2023) to $3.794B (2025) (10-K 2025, Consolidated Statements of Operations).
• Operating margin compression: Operating margin fell from 9.2% (2023) to 7.2% (2024) to 4.6% (2025) as R&D rose 61% and SG&A 22% over the same span while revenue was flat (10-K 2025, Consolidated Statements of Operations).
• Regulatory credits revenue declining: Automotive regulatory credits fell 28% to $1.993B in 2025 (10-K 2025, Consolidated Statements of Operations) and a further 67% YoY in Q2 2026 to $146M (10-Q 2026-06-30, Results of Operations).
• Warranty reserve ballooning: Accrued warranty reserve grew from $5.152B (2023) to $6.716B (2024) to $8.607B (2025), a 67% increase in two years (10-K 2025, Note 13 – Warranties).
• Massive unrecognized stock compensation: The 2025 CEO Performance Award carries $10.23B unrecognized expense for a probable milestone and $105.8B–$120.4B for improbable milestones as of Dec 31, 2025 (10-K 2025, Note 11 – 2025 CEO Performance Award).
• Six-month free cash flow decline: Despite 84% higher operating cash flow ($8.63B vs $4.70B), six-month free cash flow fell to $358M in H1 2026 from $809M in H1 2025 due to CapEx more than doubling to $8.28B (10-Q 2026-06-30, MD&A Overview; Consolidated Statements of Cash Flows).
• CapEx guidance step-up: Management expects 2026 CapEx "in excess of $25 billion" versus $8.53B spent in 2025 (10-Q 2026-06-30, Cash Flow and Capital Expenditure Trends).
• Other income volatility: Other (expense) income swung from a $695M gain (2024) to a $419M loss (2025) driven by Bitcoin mark-to-market and FX on intercompany balances (10-K 2025, MD&A – Other Income (Expense), Net).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Overall Assessment: Annual GAAP earnings have deteriorated sharply across the three-year period. Total revenue peaked at $97.69B in 2024 before falling 3% to $94.83B in 2025 (10-K 2025, Consolidated Statements of Operations). Net income attributable to common stockholders declined 46% in 2025 to $3.79B after a 53% drop in 2024 (10-K 2025, Consolidated Statements of Operations). Operating income fell 38% in 2025 to $4.36B, pushing operating margin to 4.6% from 7.2% in 2024 and 9.2% in 2023 (10-K 2025, Consolidated Statements of Operations). The decline was driven by a 9% drop in automotive sales revenue to $65.8B, a 28% drop in high-margin regulatory credits to $2.0B, and a 41% surge in R&D to $6.41B plus a 13% rise in SG&A to $5.83B (10-K 2025, MD&A – Revenues; Research and Development Expense; Selling, General and Administrative Expense). Gross margin was roughly stable at 18.0% in 2025 vs 17.9% in 2024, but the automotive & services segment margin slipped to 16.2% from 16.9% (10-K 2025, MD&A – Cost of Revenues and Gross Margin). Quarterly Q2 2026 showed revenue growth of 26% YoY but net income attributable to common stockholders dipped 5% to $1.11B (10-Q 2026-06-30, MD&A Overview; Results of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Overall Assessment: Annual cash generation has improved on a free-cash-flow basis despite flat operating cash flow. Operating cash flow held near $14.9B in both 2024 and 2025 ($14.92B vs $14.75B) after rising from $13.26B in 2023 (10-K 2025, Consolidated Statements of Cash Flows). Capital expenditures fell 25% to $8.53B in 2025 from $11.34B in 2024, lifting free cash flow (operating cash flow minus CapEx) to $6.22B in 2025 from $3.58B in 2024 and $4.36B in 2023 (10-K 2025, Consolidated Statements of Cash Flows). Cash and short-term investments grew to $44.06B at year-end 2025 from $36.56B at year-end 2024 (10-K 2025, Consolidated Balance Sheets; Note 4). In the first half of 2026, operating cash flow surged 84% YoY to $8.63B, but CapEx more than doubled to $8.28B, reducing six-month free cash flow to $358M from $809M (10-Q 2026-06-30, MD&A Overview; Consolidated Statements of Cash Flows). Cash and short-term investments ended Q2 2026 at $43.52B, down $535M from year-end 2025 (10-Q 2026-06-30, MD&A Overview).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Insufficient Data

Overall Assessment: The consolidated balance sheets in the provided filings present only two annual periods (Dec 31, 2025 and Dec 31, 2024), which is insufficient to establish a multi-period trajectory per the required minimum of two comparable periods for a trend assessment (10-K 2025, Consolidated Balance Sheets). Between those two dates, total assets grew 13% to $137.8B, cash and short-term investments rose 20% to $44.1B, total debt increased modestly to $8.18B from $7.91B, and stockholders' equity rose 13% to $82.1B (10-K 2025, Consolidated Balance Sheets; Note 9). Inventory and accounts receivable grew modestly (3% and 4% respectively) while accounts payable rose 7% (10-K 2025, Consolidated Balance Sheets; Note 5; Note 7). Without a third annual balance sheet (2023) in the provided data, a trajectory tag cannot be assigned.

6. Data Gaps

• Quarterly income statements and cash flow statements for Q1 2026, Q3 2025, and Q2 2025 (the 10-Qs for periods 2026-03-31, 2025-09-30, and 2025-06-30 are listed as provided but their financial statement contents are not included in the filing text).
• Annual balance sheet for 2023 (only 2025 and 2024 are presented in the 10-K Consolidated Balance Sheets).
• Standalone Q2 2026 cash flow statement (the 10-Q 2026-06-30 provides only six-month cash flow data).
• Segment-level quarterly revenue and gross profit detail for periods prior to Q2 2026.
• Full-year 2026 actual results (only outlook/guidance provided).